BMJ  2007;335:508-512 (8 September), doi:10.1136/bmj.39255.669444.AE

Practice

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

A A Tahrani, specialist registrar in diabetes and endocrinology, G I Varughese, specialist registrar in diabetes and endocrinology, J H Scarpello, consultant physician, F W F Hanna, consultant physician in diabetes and endocrinology

Department of Diabetes and Endocrinology, University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG

Correspondence to: A A Tahrani  abdtahrani@yahoo.co.uk

Many patients with type 2 diabetes are denied treatment with metformin because of "contraindications" such as cardiac failure, which may not be absolute contraindications

The first 150 words of the full text of this article appear below.

Introduction


Summary points

Treatment with metformin is not associated with an increased risk of lactic acidosis among patients with type 2 diabetes mellitus who have no cardiac, renal, or liver failure
Despite increasing disregard of contraindications to metformin by physicians, the incidence of lactic acidosis has not increased, so metformin may be safe even in patients with "contraindications"
The vast majority of case reports relating metformin to lactic acidosis report at least one other disease/illness that could result in lactic acidosis
Use of metformin in patients with heart failure might be associated with lower mortality and morbidity, with no increase in hospital admissions and no documented increased risk of lactic acidosis
Further studies are needed to assess the risk of lactic acidosis in patients with type 2 diabetes and traditional contraindications to metformin


Metformin first became available in the United Kingdom in 1957 but was first prescribed in the United States only in . . . [Full text of this article]

Current contraindications to metformin use

Data sources

Metformin and risk of lactic acidosis: what evidence?

Cardiac failure and metformin

Conclusions


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Focus on diabetes
Fiona Godlee
BMJ 2007 335: 0. [Extract] [Full Text]

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
Irene M Stratton, Amanda I Adler, H Andrew W Neil, David R Matthews, Susan E Manley, Carole A Cull, David Hadden, Robert C Turner, and Rury R Holman
BMJ 2000 321: 405-412. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Bodmer, M., Meier, C., Krahenbuhl, S., Jick, S. S., Meier, C. R. (2008). Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia: A nested case-control analysis. Diabetes Care 31: 2086-2091 [Abstract] [Full text]  

Rapid Responses:

Read all Rapid Responses

Metformin in Heart Failure
Mahmood Ahmad
bmj.com, 2 Nov 2007 [Full text]
Reconciling Clinical Decision making and Traditional Contraindications
Catherine Goulding, et al.
bmj.com, 21 Nov 2007 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ